Global Fragment Based Drug Discovery Market Is Trending By Advancement In Fragment Libraries

The Global Fragment Based Drug Discovery Market comprises screening technologies such as nuclear magnetic resonance (NMR),x-ray crystallography (XRC), and surface plasmon resonance (SPR) spectroscopy. Fragment based drug discovery enables identification of fragments with high efficiency by using biophysical techniques. It has advantages over high-throughput screening as it allows identification of fragments with novel chemical matter and optimization towards quality leads.

The Global Fragment Based Drug Discovery Market is estimated to be valued at US$ 0.795 Bn in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the global fragment based drug discovery are Astex Pharmaceuticals,Beactica AB,Charles River Laboratories International, Inc.,Evotec AG,Alveus Pharmaceuticals Pvt. Ltd.. Astex Pharmaceuticals has a fragment library with over 250,000 fragments used for drug discovery. Beactica AB provides fragment based drug discovery services and a fragment library of over 80,000 fragments for identifying novel starting points.

The growing prevalence of chronic diseases and rising R&D expenditure in pharmaceutical companies are driving the demand for fragment based drug discovery.Fragment based drug discovery helps in identifying novel starting points in a cost effective manner as compared to high throughput screening.

The Global Fragment Based Drug Discovery Market is also witnessing expansion in Asia Pacific and Latin America due to establishment of new research facilities and outsourcing of early stage drug discovery to CROs in these regions by major players.

Market Key Trends

One of the key trends in the Global Fragment Based Drug Discovery Market is advancement in fragment libraries. Earlier fragment libraries included a limited set of fragments but now comprehensive fragment collections consisting of millions of diverse fragments are available off the shelf from various vendors. For example, Astex Pharmaceuticals offers the Pharmaphoric fragment collection, which is one of the largest commercially available fragment collections, containing over 1.2 million fragments. Such expanded fragment libraries provide opportunities for identification of novel fragments and scaffolds in drug discovery programs.

Porter’s Analysis

Threat of new entrants: The threat is moderate as significant capital investment is required for research and facilities. However, collaborations can help lower entry barriers.

Bargaining power of buyers: Buyers have moderate bargaining power as there are many vendors for outsourced services. However, intellectual property is important for buyers.

Bargaining power of suppliers: Suppliers have low to moderate bargaining power as there are many component providers and outsourcing companies.

Threat of new substitutes: The threat is low as substitutes are niche and fragmented based technologies.

Competitive rivalry: Rivalry is high as the market is growing and players are offering integrated and specialized services to gain market share.

Geographical Regions

North America accounted for the largest share of the Global Fragment Based Drug Discovery Market in terms of value in 2024 owing to increasing R&D investments by pharmaceutical companies. The presence of major market players and academic research institutes driving outsourcing is a key factor.

The Asia Pacific region is expected to witness the fastest growth during the forecast period due to increasing government funding for pharmaceutical research, low operational costs, and growing expertise in molecular modeling and libraries in countries like China and India. Collaborations with global players are also allowing regional capabilities to grow.

What Are The Key Data Covered In This Global Fragment Based Drug Discovery Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Fragment Based Drug Discovery Market’s growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Fragment Based Drug Discovery Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Global Fragment Based Drug Discovery Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Fragment Based Drug Discovery Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global Fragment Based Drug Discovery Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Global Fragment Based Drug Discovery Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Global Fragment Based Drug Discovery Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it